139 related articles for article (PubMed ID: 26753381)
1. Anal squamous cell carcinoma in HIV/AIDS patients in the HAART era: Report of 8 cases and literature review.
Corti M; Villafañe MF; Priarone MM; Vittar N; Lewi D; Marona E; Gilardi L
Acta Gastroenterol Latinoam; 2014; 44(4):305-10. PubMed ID: 26753381
[TBL] [Abstract][Full Text] [Related]
2. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience.
Martellotta F; Berretta M; Cacopardo B; Fisichella R; Schioppa O; Zanghì A; Spartà D; Cappellani A; Talamini R; Izzi I; Ridolfo A; Torresin A; Fiorica F; Tirelli U
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1283-91. PubMed ID: 23047514
[TBL] [Abstract][Full Text] [Related]
5. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.
Place RJ; Gregorcyk SG; Huber PJ; Simmang CL
Dis Colon Rectum; 2001 Apr; 44(4):506-12. PubMed ID: 11330577
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
[TBL] [Abstract][Full Text] [Related]
7. Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients.
Abramowitz L; Mathieu N; Roudot-Thoraval F; Lemarchand N; Bauer P; Hennequin C; Mitry E; Romelaer C; Aparicio T; Sobhani I
Aliment Pharmacol Ther; 2009 Aug; 30(4):414-21. PubMed ID: 19392867
[TBL] [Abstract][Full Text] [Related]
8. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
[TBL] [Abstract][Full Text] [Related]
9. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?
Pappou EP; Magruder JT; Fu T; Hicks CW; Herman JM; Fang S; Wick EC; Safar B; Gearhart SL; Efron JE
World J Surg; 2018 Mar; 42(3):876-883. PubMed ID: 28948325
[TBL] [Abstract][Full Text] [Related]
11. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.
Stadler RF; Gregorcyk SG; Euhus DM; Place RJ; Huber PJ; Simmang CL
Dis Colon Rectum; 2004 Aug; 47(8):1305-9. PubMed ID: 15484343
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
13. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
14. HAART slows progression to anal cancer in HIV-infected MSM.
Duncan KC; Chan KJ; Chiu CG; Montaner JS; Coldman AJ; Cescon A; Au-Yeung CG; Wiseman SM; Hogg RS; Press NM
AIDS; 2015 Jan; 29(3):305-11. PubMed ID: 25686679
[TBL] [Abstract][Full Text] [Related]
15. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
17. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
Palefsky JM
Semin Oncol; 2000 Aug; 27(4):471-9. PubMed ID: 10950374
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy.
Diamond C; Taylor TH; Aboumrad T; Bringman D; Anton-Culver H
Sex Transm Dis; 2005 May; 32(5):314-20. PubMed ID: 15849533
[TBL] [Abstract][Full Text] [Related]
19. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
[TBL] [Abstract][Full Text] [Related]
20. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
